IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Int J Cancer. 2019 Oct 1;145(7):1913-1920. doi: 10.1002/ijc.32286. Epub 2019 Apr 9.
Colorectal cancer (CRC) is one of the most malignant tumors worldwide. Stromal cells residing in the tumor microenvironment strongly contribute to cancer progression through their crosstalk with cancer cells and extracellular matrix. Here we provide the first evidence that CRC-associated lymphatic endothelium displays a distinct matrisome-associated transcriptomic signature, which distinguishes them from healthy intestinal lymphatics. We also demonstrate that CRC-associated human intestinal lymphatic endothelial cells regulate tumor cell growth via growth differentiation factor 11, a soluble matrisome component which in CRC patients was found to be associated with tumor progression. Our data provide new insights into lymphatic contribution to CRC growth, aside from their conventional role as conduits of metastasis.
结直肠癌(CRC)是全球最恶性的肿瘤之一。肿瘤微环境中的基质细胞通过与癌细胞和细胞外基质的相互作用,强烈促进癌症的进展。在这里,我们首次提供证据表明,与 CRC 相关的淋巴内皮细胞表现出独特的基质相关转录组特征,这使它们与健康的肠道淋巴管区分开来。我们还证明,与 CRC 相关的人肠道淋巴内皮细胞通过生长分化因子 11 调节肿瘤细胞的生长,生长分化因子 11 是一种可溶性基质成分,在 CRC 患者中发现其与肿瘤进展相关。我们的数据提供了新的见解,即除了作为转移途径的传统作用外,淋巴对 CRC 生长的贡献。